WallStreetZenWallStreetZen

NASDAQ: OCUL
Ocular Therapeutix Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for OCUL

Based on 6 analysts offering 12 month price targets for Ocular Therapeutix Inc

Min Forecast
$14.00+100.86%
Avg Forecast
$23.33+234.76%
Max Forecast
$30.00+330.42%

Should I buy or sell OCUL stock?

Based on 6 analysts offering ratings for Ocular Therapeutix Inc.

Strong Buy
Strong Buy
2 analysts 33.33%
Buy
4 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although OCUL's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates OCUL as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their OCUL stock forecasts and price targets.

OCUL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-10-19
lockedlocked$00.00+00.00%2026-10-12
lockedlocked$00.00+00.00%2026-10-02
lockedlocked$00.00+00.00%2026-09-16
lockedlocked$00.00+00.00%2026-06-18
RBC Capital
Top 29%
72
BuyReiterates$30.00+310.40%2026-05-06

1 of 1

Forecast return on equity

Is OCUL forecast to generate an efficient return?

Company
0.22%
Industry
21.4%
Market
176.67%
OCUL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is OCUL forecast to generate an efficient return on assets?

Company
0.17%
Industry
21.92%
OCUL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

OCUL earnings per share forecast

What is OCUL's earnings per share in the next 3 years based on estimates from 15 analysts?

Avg 1 year Forecast
-$1.53
Avg 2 year Forecast
-$1.51
Avg 3 year Forecast
-$1.07

OCUL revenue forecast

What is OCUL's revenue in the next 3 years based on estimates from 15 analysts?

Avg 1 year Forecast
$53.8M+3.4%
Avg 2 year Forecast
$102.4M+96.64%
Avg 3 year Forecast
$273.8M+425.93%
OCUL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

OCUL revenue growth forecast

How is OCUL forecast to perform vs Biotechnology companies and vs the US market?

Company
67.14%
Industry
29.98%
Market
12.67%
OCUL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OCUL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OCUL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
OCUL$7.31$23.33+219.19%Strong Buy
IMCR$31.27$61.67+97.21%Buy
TRAX$45.23$74.20+64.07%Strong Buy
URGN$33.48$57.00+70.25%Strong Buy
GPCR$21.94$92.33+320.84%Strong Buy
View Top Biotech Stocks

Ocular Therapeutix Stock Forecast FAQ

Is Ocular Therapeutix Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: OCUL) stock is to Strong Buy OCUL stock.

Out of 6 analysts, 2 (33.33%) are recommending OCUL as a Strong Buy, 4 (66.67%) are recommending OCUL as a Buy, 0 (0%) are recommending OCUL as a Hold, 0 (0%) are recommending OCUL as a Sell, and 0 (0%) are recommending OCUL as a Strong Sell.

If you're new to stock investing, here's how to buy Ocular Therapeutix stock.

What is OCUL's earnings growth forecast for 2026-2028?

(NASDAQ: OCUL) Ocular Therapeutix's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.01%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.56%.

Ocular Therapeutix's earnings in 2026 is -$301,447,000.On average, 15 Wall Street analysts forecast OCUL's earnings for 2026 to be -$335,177,738, with the lowest OCUL earnings forecast at -$335,748,739, and the highest OCUL earnings forecast at -$325,141,293. On average, 15 Wall Street analysts forecast OCUL's earnings for 2027 to be -$331,751,730, with the lowest OCUL earnings forecast at -$400,096,188, and the highest OCUL earnings forecast at -$209,842,962.

In 2028, OCUL is forecast to generate -$234,857,209 in earnings, with the lowest earnings forecast at -$365,880,036 and the highest earnings forecast at -$103,768,498.

What is OCUL's revenue growth forecast for 2026-2028?

(NASDAQ: OCUL) Ocular Therapeutix's forecast annual revenue growth rate of 67.14% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31.15%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.98%.

Ocular Therapeutix's revenue in 2026 is $52,054,000.On average, 15 Wall Street analysts forecast OCUL's revenue for 2026 to be $11,821,043,711, with the lowest OCUL revenue forecast at $10,933,356,373, and the highest OCUL revenue forecast at $12,961,948,145. On average, 15 Wall Street analysts forecast OCUL's revenue for 2027 to be $22,479,880,248, with the lowest OCUL revenue forecast at $12,482,965,937, and the highest OCUL revenue forecast at $42,199,189,036.

In 2028, OCUL is forecast to generate $60,124,236,182 in revenue, with the lowest revenue forecast at $13,214,726,009 and the highest revenue forecast at $98,939,144,693.

What is OCUL's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: OCUL) forecast ROA is 0.17%, which is lower than the forecast US Biotechnology industry average of 22.87%.

What is OCUL's Price Target?

According to 6 Wall Street analysts that have issued a 1 year OCUL price target, the average OCUL price target is $23.33, with the highest OCUL stock price forecast at $30.00 and the lowest OCUL stock price forecast at $14.00.

On average, Wall Street analysts predict that Ocular Therapeutix's share price could reach $23.33 by Oct 19, 2027. The average Ocular Therapeutix stock price prediction forecasts a potential upside of 219.19% from the current OCUL share price of $7.31.

What is OCUL's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: OCUL) Ocular Therapeutix's current Earnings Per Share (EPS) is -$1.40. On average, analysts forecast that OCUL's EPS will be -$1.53 for 2026, with the lowest EPS forecast at -$1.53, and the highest EPS forecast at -$1.48. On average, analysts forecast that OCUL's EPS will be -$1.51 for 2027, with the lowest EPS forecast at -$1.82, and the highest EPS forecast at -$0.96. In 2028, OCUL's EPS is forecast to hit -$1.07 (min: -$1.67, max: -$0.47).

What is OCUL's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: OCUL) forecast ROE is 0.22%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.